References
- Boomsma CM, Fauser B, Macklon NS. 2008. Pregnancy complications in women with polycystic ovary syndrome. Seminars in Reproductive Medicine 26:072–084.
- Catalano PM, McIntyre DH, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. 2012. The hyperglycemia and adverse pregnancy outcome study. Diabetes Care 35:780–786.
- Clinical and Laboratory Standards Institute (CLSI). Clinical Laboratory Technical Procedure Manuals; Approved Guideline, GP02-A5, 2006.
- Craig LB, Ke RW, Kutteh WH. 2002. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertility and Sterility 78:487–490.
- Glueck JC, Pranikoff J, Aregawi D, Wang P. 2008. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertility and Sterility 86:625–634.
- Gordon MC, Zimmerman PD, Landon MB, Gabbe SG, Kniss DA. 1995. Insulin and glucose modulate glucose messenger ribonucleic acid expression and glucose uptake in trophoblasts isolated from first-trimester chorionic villi. American Journal of Obstetrics and Gynecology 173:189–197.
- Jakubowicz DJ, Essah PA, Seppälä M, Jakubowicz S, Baillargeon J-P, Koistinen R, et al. 2004. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. The Journal of Clinical Endocrinology and Metabolism 89:833–839.
- Lee C-L, Lam KKW, Vijayan M, Koistinen H, Seppala M, Ng EHY, et al. 2016. The pleiotropic effect of glycodelin-A in early pregnancy. American Journal of Reproductive Immunology 75:290–297.
- Wang Y, Zhao H, Li Y, Zhang J, Tan J, Liu Y. 2011. Relationship between recurrent miscarriage and insulin resistance. Gynecologic and Obstetric Investigation 72:245–251.